216 related articles for article (PubMed ID: 33624534)
41. Health care costs and resource utilization among commercially insured adult patients with hemophilia A managed with FVIII prophylaxis in the United States.
Thornburg CD; Adamski K; Cook K; Vembusubramanian M; Sendhil SR; Hinds D; Chen E; Sammon J; Solari P; Garrison LP; Croteau SE
J Manag Care Spec Pharm; 2022 Apr; 28(4):449-460. PubMed ID: 34958235
[No Abstract] [Full Text] [Related]
42. Health care resource utilization and costs associated with treatment among patients initiating calcitonin gene-related peptide inhibitors vs other preventive migraine treatments in the United States.
Varnado OJ; Manjelievskaia J; Ye W; Perry A; Schuh K; Wenzel R
J Manag Care Spec Pharm; 2022 Aug; 28(8):818-829. PubMed ID: 35876297
[No Abstract] [Full Text] [Related]
43. Is outpatient spine surgery associated with new, persistent opioid use in opioid-naïve patients? A retrospective national claims database analysis.
Schultz E; Zhuang T; Shapiro LM; Hu SS; Kamal RN
Spine J; 2023 Oct; 23(10):1451-1460. PubMed ID: 37355048
[TBL] [Abstract][Full Text] [Related]
44. Prevalence and Cost of Subsequent Fractures Among U.S. Patients with an Incident Fracture.
Weaver J; Sajjan S; Lewiecki EM; Harris ST; Marvos P
J Manag Care Spec Pharm; 2017 Apr; 23(4):461-471. PubMed ID: 28345441
[TBL] [Abstract][Full Text] [Related]
45. Health Care Resource Utilization and Costs for Patients with Tardive Dyskinesia.
Carroll B; Irwin DE
J Manag Care Spec Pharm; 2019 Jul; 25(7):810-816. PubMed ID: 31232207
[TBL] [Abstract][Full Text] [Related]
46. Healthcare resource utilization and costs 2 years pre- and post-lumbar spine surgery for stenosis: a national claims cohort study of 22,182 cases.
Koltsov JCB; Sambare TD; Alamin TF; Wood KB; Cheng I; Hu SS
Spine J; 2022 Jun; 22(6):965-974. PubMed ID: 35123048
[TBL] [Abstract][Full Text] [Related]
47. Incremental Effect of the Addition of Prescriber Restrictions on a State Medicaid's Pharmacy-Only Patient Review and Restriction Program.
Keast SL; Pham T; Teel A; Nesser NJ
J Manag Care Spec Pharm; 2017 Aug; 23(8):875-883. PubMed ID: 28737989
[TBL] [Abstract][Full Text] [Related]
48. Health Care Utilization and Cost Associated with Biologic Treatment Patterns Among Patients with Moderate to Severe Psoriasis: Analyses from a Large U.S. Claims Database.
Feldman SR; Tian H; Wang X; Germino R
J Manag Care Spec Pharm; 2019 Apr; 25(4):479-488. PubMed ID: 30556761
[TBL] [Abstract][Full Text] [Related]
49. High-Cost Sarcoidosis Patients in the United States: Patient Characteristics and Patterns of Health Care Resource Utilization.
Rice JB; White A; Lopez A; Nelson WW
J Manag Care Spec Pharm; 2017 Dec; 23(12):1261-1269. PubMed ID: 29172980
[TBL] [Abstract][Full Text] [Related]
50. Short-acting and Long-acting Opioids Utilization among Women Diagnosed with Endometriosis in the United States: A Population-based Claims Study.
As-Sanie S; Soliman AM; Evans K; Erpelding N; Lanier RK; Katz NP
J Minim Invasive Gynecol; 2021 Feb; 28(2):297-306.e2. PubMed ID: 32531340
[TBL] [Abstract][Full Text] [Related]
51. Economic burden of peanut allergy in pediatric patients with evidence of reactions to peanuts in the United States.
Blaiss MS; Meadows JA; Yu S; Robison DR; Hass SL; Norrett KE; Guerin A; Latremouille-Viau D; Tilles SA
J Manag Care Spec Pharm; 2021 Apr; 27(4):516-527. PubMed ID: 33470880
[No Abstract] [Full Text] [Related]
52. Economic burden of growth hormone deficiency in a US pediatric population.
Kaplowitz P; Manjelievskaia J; Lopez-Gonzalez L; Morrow CD; Pitukcheewanont P; Smith A
J Manag Care Spec Pharm; 2021 Aug; 27(8):1118-1128. PubMed ID: 33896224
[No Abstract] [Full Text] [Related]
53. Costs of gastrointestinal events after outpatient opioid treatment for non-cancer pain.
Kwong WJ; Diels J; Kavanagh S
Ann Pharmacother; 2010 Apr; 44(4):630-40. PubMed ID: 20197473
[TBL] [Abstract][Full Text] [Related]
54. The Economic Burden of Opioid Abuse: Updated Findings.
Kirson NY; Scarpati LM; Enloe CJ; Dincer AP; Birnbaum HG; Mayne TJ
J Manag Care Spec Pharm; 2017 Apr; 23(4):427-445. PubMed ID: 28345440
[TBL] [Abstract][Full Text] [Related]
55. Healthcare resource utilization and costs by disease severity in an insured national sample of US patients with chronic hepatitis B.
Nguyen MH; Burak Ozbay A; Liou I; Meyer N; Gordon SC; Dusheiko G; Lim JK
J Hepatol; 2019 Jan; 70(1):24-32. PubMed ID: 30287341
[TBL] [Abstract][Full Text] [Related]
56. Burden of illness among patients with dementia-related psychosis.
Frazer M; Abler V; Halpern R; Skoog B; Rashid N
J Manag Care Spec Pharm; 2021 Mar; 27(3):367-378. PubMed ID: 33645238
[No Abstract] [Full Text] [Related]
57. Assessment of racial and ethnic inequities in copay card utilization and enrollment in copay adjustment programs.
Ingham M; Sadik K; Zhao X; Song J; Fendrick AM
J Manag Care Spec Pharm; 2023 Sep; 29(9):1084-1092. PubMed ID: 37548953
[No Abstract] [Full Text] [Related]
58. National cost of trauma care by payer status.
Velopulos CG; Enwerem NY; Obirieze A; Hui X; Hashmi ZG; Scott VK; Cornwell EE; Schneider EB; Haider AH
J Surg Res; 2013 Sep; 184(1):444-9. PubMed ID: 23800441
[TBL] [Abstract][Full Text] [Related]
59. Healthcare costs and utilization associated with high-risk prescription opioid use: a retrospective cohort study.
Chang HY; Kharrazi H; Bodycombe D; Weiner JP; Alexander GC
BMC Med; 2018 May; 16(1):69. PubMed ID: 29764482
[TBL] [Abstract][Full Text] [Related]
60. Characterizing downstream healthcare resource utilization and costs based on prior utilization patterns of immediate-release hydrocodone.
Ben-Joseph R; Bell JA; Chitnis A; Kansal A; Holly P; Paramore C; Wild H
J Med Econ; 2016; 19(2):169-80. PubMed ID: 26451633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
